These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2156074)

  • 1. Potential mechanisms of resistance to the modern fluorinated 4-quinolones.
    Lewin CS; Allen RA; Amyes SG
    J Med Microbiol; 1990 Mar; 31(3):153-62. PubMed ID: 2156074
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mechanisms of bacterial resistance to quinolones].
    Yoshida H
    Nihon Saikingaku Zasshi; 1996 Oct; 51(4):973-92. PubMed ID: 8994343
    [No Abstract]   [Full Text] [Related]  

  • 3. Proportion of DNA gyrase mutants among quinolone-resistant strains of Pseudomonas aeruginosa.
    Yoshida H; Nakamura M; Bogaki M; Nakamura S
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1273-5. PubMed ID: 2168149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between disc potency and zone size in temafloxacin activity in vitro.
    Reggio S; Bassanetti I; Ceralli M; Giardini R; Sansonetti G
    Drugs Exp Clin Res; 1990; 16(12):611-4. PubMed ID: 2130003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tobramycin: in vitro antibacterial spectrum of a new aminoglycoside.
    Meyers BR; Hirschman SZ
    J Clin Pharmacol New Drugs; 1972; 12(8):313-20. PubMed ID: 4626620
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanisms of resistance to the 4-quinolone antibacterial agents.
    Crumplin GC
    J Antimicrob Chemother; 1990 Dec; 26 Suppl F():131-44. PubMed ID: 1963425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mode of actions and mechanisms of resistance of new quinolones in Pseudomonas aeruginosa].
    Hirai K; Hashimoto H
    Nihon Rinsho; 1991 Oct; 49(10):2261-5. PubMed ID: 1660943
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antimicrobial drug therapy and microbial sensitivity tests: general concept of antibiotics].
    Miyazakin S; Yamaguchi K
    Rinsho Byori; 1997 Jul; Suppl 105():162-73. PubMed ID: 9379536
    [No Abstract]   [Full Text] [Related]  

  • 9. Bacterial resistance to quinolones: mechanisms and clinical importance.
    Wolfson JS; Hooper DC
    Rev Infect Dis; 1989; 11 Suppl 5():S960-8. PubMed ID: 2549610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison between the activity of 2 amino-glycoside antibiotics, tobramycin and gentamicin on gram negative bacteria in vitro].
    De Rosa F; Tassi C; Stagni GR
    Ann Sclavo; 1974; 16(1):65-72. PubMed ID: 4214247
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro sensitivity pattern of gram negative pathogens to nalidixic acid.
    Chitkara YK
    Indian J Pathol Bacteriol; 1969 Oct; 12(4):162-8. PubMed ID: 4990210
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evaluation of the in vitro effect of ceftazidime and 12 other antibiotics on gram-negative bacteria isolated from a hospital environment].
    Goglio A; Obiso D; Donadini C; Perani V
    G Ital Chemioter; 1984; 31(3):219-22. PubMed ID: 6442982
    [No Abstract]   [Full Text] [Related]  

  • 13. Trimethoprim-sensitivity testing and thymineless mutants.
    Amyes SG; Smith JT
    J Med Microbiol; 1974 May; 7(2):143-53. PubMed ID: 4209268
    [No Abstract]   [Full Text] [Related]  

  • 14. Emergence of bacteria resistant to gentamicin.
    Henri A; Daneau D; Klastersky J
    Int J Clin Pharmacol; 1973 Nov; 8(3):216-21. PubMed ID: 4203920
    [No Abstract]   [Full Text] [Related]  

  • 15. Low antibiotic resistance rates in Staphylococcus aureus, Escherichia coli and Klebsiella spp but not in Enterobacter spp and Pseudomonas aeruginosa: a prospective observational study in 14 Swedish ICUs over a 5-year period.
    Hanberger H; Burman LG; Cars O; Erlandsson M; Gill H; Nilsson LE; Nordlinder D; Walther SM;
    Acta Anaesthesiol Scand; 2007 Aug; 51(7):937-41. PubMed ID: 17635399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA gyrase as a drug target.
    Maxwell A
    Biochem Soc Trans; 1999 Feb; 27(2):48-53. PubMed ID: 10093705
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mechanisms for the development of quinolone resistance].
    Kojima M
    Nihon Rinsho; 1997 May; 55(5):1252-60. PubMed ID: 9155183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasmids and genetic determinants of antibiotic resistance of gram-negative bacteria].
    Erova TE; Anisimova LA; Smolianskaia AZ; Boronin AM
    Antibiot Khimioter; 1989 May; 34(5):365-70. PubMed ID: 2500901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-level quinolone resistance in Pseudomonas aeruginosa.
    Piddock LJ; Panchal S; Inglis TJ; Hawkey PM
    J Antimicrob Chemother; 1992 Aug; 30(2):229-31. PubMed ID: 1399933
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacodynamic and pharmacokinetic approaches to optimization of lomefloxacin].
    Iakovlev SV
    Antibiot Khimioter; 1998; 43(10):42-5. PubMed ID: 9825110
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.